| Medicare Noridian | Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (57901) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Pigmented Lesion Assay (58052) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (58181) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (58183) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (58454) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (58679) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (58720) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (58973) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (58996) | 2026-01-26 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules (59509) | 2026-01-26 |